Skip to main content

2024-25 Surgical Pathology/Surgical Pathology Subspecialty Fellowship

Application Window

Open date: July 1, 2022

Next review date: Sunday, Dec 31, 2023 at 11:59pm (Pacific Time)
Apply by this date to ensure full consideration by the committee.

Final date: Sunday, Dec 31, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.

Position description

The Department of Pathology and Laboratory Medicine offers from 6-10 one-year fellowships in general surgical pathology and subspecialty surgical pathology. Pathology Fellows rotate through two week and month-long assignments at a senior or supervisory level. The year is intended to provide the fellow with that last layer of confidence necessary to practice surgical pathology independently in a variety of settings from small community hospitals to large community hospitals or academic institutions. This recruitment does not include applicants for our GI/Liver fellowship. For those interested in GI/Liver fellowship, please see separate recruitment https://recruit.apo.ucla.edu/JPF07620.

Please see our website: http://pathology.ucla.edu/Non-acgmeFellowshipPrograms, for detailed information on how the fellowship year is scheduled.

For questions regarding the program(s), please contact the Fellowship Coordinator, Andrew Aldapa, Aaldapa@mednet.ucla.edu

The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy see: UC Nondiscrimination & Affirmative Action Policy.

Qualifications

Basic qualifications (required at time of application)

These positions are open to applicants who have completed training in a US or Canadian ACGME accredited AP/CP or AP only residency program. Applicant must be Board eligible or Board certified. International medical school graduates will only be considered if they have completed residency training in a US or Canadian ACGME accredited residency program. A California medical license is required on day one of appointment.

Application Requirements

Document requirements
  • Application Form - https://www.uclahealth.org/pathology/requirements

  • Curriculum Vitae - Your most recently updated C.V.

  • Personal Statement

  • Letter of Good Standing - Please provide a letter from your current PD. If your PD is a letter writer, they still have to provide the letter of good standing.

  • Statement on Contributions to Equity, Diversity, and Inclusion - An EDI Statement describes a faculty candidate‚Äôs past, present, and future (planned) contributions to equity, diversity, and inclusion. To learn more about how UCLA thinks about contributions to equity, diversity, and inclusion, please review our Sample Guidance for Candidates and related EDI Statement FAQ document.

  • Photo

  • USMLE Steps I, II, III

Reference requirements
  • 3-5 letters of reference required

References can submit letters digitally through link sent from UC Recruit system.

Apply link: https://recruit.apo.ucla.edu/JPF07619

Help contact: aaldapa@mednet.ucla.edu

About UCLA

As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.

The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy, see: UC Nondiscrimination & Affirmative Action Policy.